FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024228574> ?p ?o ?g. }

• W2024228574 endingPage "868" @default.
• W2024228574 startingPage "863" @default.
• W2024228574 abstract "Abstract Objective The antimalarial medication hydroxychloroquine has been proposed as a thromboprotective agent in systemic lupus erythematosus (SLE), but studies thus far have been limited by the possibility of confounding by indication. This study was conducted to assess whether exposure to antimalarial drugs is associated with a decrease in thrombovascular events (TEs) in patients with SLE. Methods The study was designed as a nested case–control study embedded in an inception cohort of patients with SLE, which allowed adjustments for possible confounding by calendar year, duration of disease, duration of observation, and severity of lupus. After controlling for the possible confounding variables in conditional logistic regression models, the use of antimalarial drugs was assessed for its effects on the development of TEs in lupus patients. Results Fifty‐four cases of TE were identified, and these were matched with 108 control subjects (lupus patients without TEs). Univariate analyses identified older age (odds ratio [OR] 1.04, 95% confidence interval [95%CI] 1.01–1.07) or being older than age 50 years (OR 3.5, 95% CI 1.4–8.6) and ever having hypertension (OR 2.5, 95% CI 1.0–5.8) as being associated with an increased risk of TEs, whereas use of antimalarial drugs (OR 0.31, 95% CI 0.13–0.71) was associated with a decreased risk of TEs. Separate analyses were done for arterial and venous TEs, which yielded similar results. In multivariate analyses, use of antimalarial drugs (OR 0.32, 95% CI 0.14–0.74) and older age (OR 1.04, 95% CI 1.01–1.07) were the only 2 variables that remained significant. Conclusion The results from this nested case–control study demonstrate that, after accounting for the effects of disease severity, disease duration, and calendar year, antimalarial drugs were found to be thromboprotective, being associated with a 68% reduction in the risk of all TEs, with a range of risk reduction of at least 26% up to as high as 86%." @default.
• W2024228574 created "2016-06-24" @default.
• W2024228574 creator A5009322595 @default.
• W2024228574 creator A5011252269 @default.
• W2024228574 creator A5014930895 @default.
• W2024228574 creator A5023339952 @default.
• W2024228574 creator A5049489990 @default.
• W2024228574 creator A5065280984 @default.
• W2024228574 creator A5066646408 @default.
• W2024228574 creator A5077543168 @default.
• W2024228574 date "2010-02-25" @default.
• W2024228574 modified "2023-10-16" @default.
• W2024228574 title "The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus" @default.
• W2024228574 cites W1975307585 @default.
• W2024228574 cites W1985982723 @default.
• W2024228574 cites W1989924681 @default.
• W2024228574 cites W2021290439 @default.
• W2024228574 cites W2023381761 @default.
• W2024228574 cites W2039762501 @default.
• W2024228574 cites W2050117403 @default.
• W2024228574 cites W2063088868 @default.
• W2024228574 cites W2064999867 @default.
• W2024228574 cites W2066770341 @default.
• W2024228574 cites W2073018482 @default.
• W2024228574 cites W2077806147 @default.
• W2024228574 cites W2108905161 @default.
• W2024228574 cites W2108991532 @default.
• W2024228574 cites W2119333074 @default.
• W2024228574 cites W2119483296 @default.
• W2024228574 cites W2132053014 @default.
• W2024228574 cites W2146203649 @default.
• W2024228574 cites W2165897466 @default.
• W2024228574 cites W2433718909 @default.
• W2024228574 cites W3021852519 @default.
• W2024228574 cites W4235790631 @default.
• W2024228574 cites W4242308600 @default.
• W2024228574 doi "https://doi.org/10.1002/art.27289" @default.
• W2024228574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20131232" @default.
• W2024228574 hasPublicationYear "2010" @default.
• W2024228574 type Work @default.
• W2024228574 sameAs 2024228574 @default.
• W2024228574 citedByCount "239" @default.
• W2024228574 countsByYear W20242285742012 @default.
• W2024228574 countsByYear W20242285742013 @default.
• W2024228574 countsByYear W20242285742014 @default.
• W2024228574 countsByYear W20242285742015 @default.
• W2024228574 countsByYear W20242285742016 @default.
• W2024228574 countsByYear W20242285742017 @default.
• W2024228574 countsByYear W20242285742018 @default.
• W2024228574 countsByYear W20242285742019 @default.
• W2024228574 countsByYear W20242285742020 @default.
• W2024228574 countsByYear W20242285742021 @default.
• W2024228574 countsByYear W20242285742022 @default.
• W2024228574 countsByYear W20242285742023 @default.
• W2024228574 crossrefType "journal-article" @default.
• W2024228574 hasAuthorship W2024228574A5009322595 @default.
• W2024228574 hasAuthorship W2024228574A5011252269 @default.
• W2024228574 hasAuthorship W2024228574A5014930895 @default.
• W2024228574 hasAuthorship W2024228574A5023339952 @default.
• W2024228574 hasAuthorship W2024228574A5049489990 @default.
• W2024228574 hasAuthorship W2024228574A5065280984 @default.
• W2024228574 hasAuthorship W2024228574A5066646408 @default.
• W2024228574 hasAuthorship W2024228574A5077543168 @default.
• W2024228574 hasConcept C126322002 @default.
• W2024228574 hasConcept C146304588 @default.
• W2024228574 hasConcept C151956035 @default.
• W2024228574 hasConcept C156957248 @default.
• W2024228574 hasConcept C159654299 @default.
• W2024228574 hasConcept C203014093 @default.
• W2024228574 hasConcept C2775915377 @default.
• W2024228574 hasConcept C2776912625 @default.
• W2024228574 hasConcept C2779123688 @default.
• W2024228574 hasConcept C2779134260 @default.
• W2024228574 hasConcept C3008058167 @default.
• W2024228574 hasConcept C44249647 @default.
• W2024228574 hasConcept C524204448 @default.
• W2024228574 hasConcept C71924100 @default.
• W2024228574 hasConcept C72563966 @default.
• W2024228574 hasConcept C77350462 @default.
• W2024228574 hasConceptScore W2024228574C126322002 @default.
• W2024228574 hasConceptScore W2024228574C146304588 @default.
• W2024228574 hasConceptScore W2024228574C151956035 @default.
• W2024228574 hasConceptScore W2024228574C156957248 @default.
• W2024228574 hasConceptScore W2024228574C159654299 @default.
• W2024228574 hasConceptScore W2024228574C203014093 @default.
• W2024228574 hasConceptScore W2024228574C2775915377 @default.
• W2024228574 hasConceptScore W2024228574C2776912625 @default.
• W2024228574 hasConceptScore W2024228574C2779123688 @default.
• W2024228574 hasConceptScore W2024228574C2779134260 @default.
• W2024228574 hasConceptScore W2024228574C3008058167 @default.
• W2024228574 hasConceptScore W2024228574C44249647 @default.
• W2024228574 hasConceptScore W2024228574C524204448 @default.
• W2024228574 hasConceptScore W2024228574C71924100 @default.
• W2024228574 hasConceptScore W2024228574C72563966 @default.
• W2024228574 hasConceptScore W2024228574C77350462 @default.
• W2024228574 hasIssue "3" @default.
• W2024228574 hasLocation W20242285741 @default.
• W2024228574 hasLocation W20242285742 @default.

• next